Butler-Manuel William, Rana Usman Iqbal, Zafar Mansoor, Gadi Azeem, Kiani Amarah
Internal Medicine, Conquest Hospital - East Sussex Healthcare NHS Trust, St. Leonards-on-Sea, GBR.
Gastroenterology and Hepatology, Conquest Hospital - East Sussex Healthcare NHS Trust, St. Leonards-on-Sea, GBR.
Cureus. 2022 Jan 4;14(1):e20932. doi: 10.7759/cureus.20932. eCollection 2022 Jan.
During the height of the COVID-19 pandemic, there was great relief with the global mass rollout of the Covid-19 vaccination programs. While they have proven to be safe and effective, the gradual emergence of side effects to the vaccines has undermined public trust in the vaccination program and, whilst rare, can lead to significant morbidity and mortality. The most serious was the emergence of vaccine-induced immune thrombocytopenia and thrombosis (VITT), also known as thrombosis with thrombocytopenia syndrome (TTS) or vaccine-induced prothrombotic immune thrombocytopenia (VIPIT). VITT is a serious and often fatal complication of some COVID vaccines that seem more prevalent in younger people and women. We present a case of a 48-year-old woman who presented with VITT following COVID vaccination.
在新冠疫情高峰期,随着新冠疫苗在全球大规模推广接种,人们松了一口气。虽然这些疫苗已被证明是安全有效的,但疫苗副作用的逐渐出现削弱了公众对疫苗接种计划的信任,而且这些副作用虽然罕见,但可能导致严重的发病和死亡。最严重的是疫苗诱导的免疫性血小板减少症和血栓形成(VITT),也称为伴有血小板减少症的血栓形成综合征(TTS)或疫苗诱导的促血栓形成免疫性血小板减少症(VIPIT)。VITT是一些新冠疫苗的严重且往往致命的并发症,似乎在年轻人和女性中更为普遍。我们报告一例48岁女性在接种新冠疫苗后出现VITT的病例。